Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
Open Access
- 1 October 2016
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 29 (10), 1155-1164
- https://doi.org/10.1038/modpathol.2016.109
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- An international study to increase concordance in Ki67 scoringLaboratory Investigation, 2015
- Triple-Negative Breast Cancer: Immune Modulation as the New Treatment ParadigmAsco Educational Book, 2015
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Annals of Oncology, 2014
- Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trialThe Lancet Oncology, 2014
- The immune system and response to HER2-targeted treatment in breast cancerThe Lancet Oncology, 2014
- Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto TrialPLOS ONE, 2013
- An International Ki67 Reproducibility StudyJNCI Journal of the National Cancer Institute, 2013
- Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)Breast Cancer Research and Treatment, 2013
- Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled AnalysisJournal of Clinical Oncology, 2012
- Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancerBreast Cancer Research, 2011